• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Drug-Device Combinations

Apiject to open new injectable drug manufacturing facility in North Carolina

January 16, 2026 By Sean Whooley

Apiject

Apiject announced today that it signed a lease on a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The injection delivery system developer plans for the new facility to house two advanced blow-fill-seal (BFS) production lines and serve as an outsourcing facility focused on producing essential generic injectable medicines currently on the FDA’s drug shortage […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: ApiJect Systems

Abbott reportedly looks to expand CGM manufacturing plant in Ireland

January 15, 2026 By Sean Whooley

Abbott FreeStyle Libre Manufacturing Plant Kilkenny Ireland

Kilkenny Live reports that Abbott (NYSE:ABT) is seeking permission to expand its facility in Kilkenny, Ireland. According to the report, Abbott hopes to extend its existing industrial building and alter its vehicle entrance and parking lot at the IDA Business and Technology Park in Kilkenny. The report states that the proposed extension would result in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott

ENvue Medical launches OTC reusable syringes

January 14, 2026 By Sean Whooley

ENvue Medical ENFit syringe (1)

ENvue Medical (Nasdaq:NAOV) announced today that it launched a line of over-the-counter (OTC) ENFit syringes. The Tyler, Texas-based company — formerly NanoVibronix — said the OTC syringes aim to meet both feeding and medication delivery needs. NanoVibronix said last year that it was shifting its focus to ENvue and its feeding tube technology after it […]

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: ENvue Medical, NanoVibronix

New Dexcom CEO Jake Leach talks 2026 roadmap, next-gen tech

January 14, 2026 By Sean Whooley

Dexcom CEO Jake Leach Headshot

After more than 100 days in the corner office at CGM maker Dexcom (NSDQ:DXCM), CEO Jake Leach is excited for the company’s future. In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession process. He took over a few months early as outgoing […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Sequel Med Tech, Diabeloop to integrate automated insulin delivery algorithm into twiist pump

January 13, 2026 By Sean Whooley

sequel twiist automated insulin delivery AID system

Sequel Med Tech and Diabeloop today announced a collaboration to integrate a new algorithm into the twiist automated insulin pump. The partnership aims to bring DBLG2, Diabeloop’s newest automated insulin delivery (AID) algorithm, to twiist. DBLG2 picked up FDA clearance last month. Sequel becomes the latest pump maker to adopt the algorithm, with ViCentra planning to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Diabeloop, Sequel Med Tech

West sells manufacturing, supply rights for on-body drug delivery system to AbbVie

January 13, 2026 By Sean Whooley

West Pharmaceutical SmartDose 3

West Pharmaceutical Services (NYSE:WST) announced that it reached an agreement to sell on-body drug delivery technology to AbbVie. The company agreed to sell all manufacturing and supply rights for the SmartDose 3.5mL on-body system and associated facilities. Exton, Pennsylvania-based West said the deal includes a total consideration of $112.5 million at close. It expects the […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals Tagged With: West Pharmaceutical, West Pharmaceutical Services

BD to invest $110M to support prefilled syringe production, pharma supply chain

January 13, 2026 By Sean Whooley

BD Neopak XtraFlow glass prefillable syringe (1)

BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska. Franklin Lakes, New Jersey-based BD aims to expand prefillable syringe production to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S. The investment brings the company’s Neopak glass prefillable syringe production to […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: BD, Becton Dickinson

Dexcom stock rises on Street-beating preliminary Q4 sales

January 12, 2026 By Sean Whooley

Dexcom updated Logo

Dexcom (NSDQ:DXCM) today announced preliminary fourth-quarter results that included revenues that topped the consensus forecast. For the quarter ended Dec. 31, 2025, the company expects total revenue of $1.26 billion. That marks a 13% increase over the same period a year ago and lands just ahead of expectations on Wall Street. Dexcom expects to report […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Medtronic wins FDA clearance for MiniMed Go app for InPen smart insulin pen

January 12, 2026 By Sean Whooley

Medtronic MiniMed Go InPen with Abbott Instinct Sensor (1)

Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI). MiniMed Go, a smart MDI system, integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within the app to deliver real-time, personalized insights and actionable guidance. Medtronic and […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Technology Tagged With: FDA, Medtronic, minimed

CamDiab earns CE mark for fully closed-loop insulin delivery algorithm

January 9, 2026 By Sean Whooley

CamDiab CamAPS FX

CamDiab announced that it received European approval for its fully closed-loop automated insulin delivery algorithm. The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal insulin. Cambridge, UK-based CamDiab said it marks the world’s first commercially available automated insulin delivery algorithm that enables people with type 1 […]

Filed Under: Diabetes, Drug-Device Combinations, Regulatory/Compliance, Technology Tagged With: CamDiab

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Interim pages omitted …
  • Page 374
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS